^
Association details:
| Biomarker: | MET expression |
|---|---|
| Cancer: | Ovarian Cancer |
| Drug: | fexagratinib (ABSK091) (FGFR inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
THE ANTI-CANCER EFFECTS OF AZD4547 ON OVARIAN CANCER CELLS: DIFFERENTIAL RESPONSES BASED ON FGF19 AND C-MET EXPRESSIONS
Published date:
10/18/2023
Excerpt:
AZD4547 significantly decreased tumor weight in xenograft models of EOC...We suggest that expression level of c-Met or FGF19 can be a predictive biomarker for AZD4547 treatment...
